YanHeng Wu

Dr YanHeng Wu is the president and managing director of Constellation International Group Holdings, a Hong Kong-based company with multiple interests in the development of new biotechnology assets including vaccines, nanotechnology, biomedical materials and minimally invasive tumour treatments. He has a PhD in tumour immunotherapy and nanocarrier technology from The University of Queensland. In 2016, Dr Wu established Guangzhou Hearty-Care Biotechnology, a medical technology company that is now owned by Constellation International Group Holdings.